Physician profile
Dwight Douglas Olson
NPI 1356351068
$868.29
in general payments reported to CMS, 2019-2025
8 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $13.37 · 2021: $385 · 2022: $124 · 2023: $188 · 2024: $158.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $287 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $58.30.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $287.22 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $58.30 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| A-Dec, INC. | $276.00 | 2021 | |
| Patterson Companies, INC. | $233.40 | 2021-2022 | |
| Straumann USA LLC | $95.69 | 2023-2024 | |
| Envista Holdings Corporation | $81.42 | 2024 | Maxcem Elite |
| Zimvie INC. | $63.77 | 2023 | |
| Inspire Medical Systems, INC. | $60.03 | 2024 | Inspire |
| Septodont INC. | $44.61 | 2023 | Bioroot Flow (Sample) |
| Zimmer Biomet Holdings, INC. | $13.37 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Dwight Olson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.